LongeVC

LongeVC is a venture capital firm based in Lugano, Switzerland, founded in 2016. The company specializes in supporting early-stage...

LongeVC invested in the British startup BioConstructiv, a company specializing in synthetic biology and biotechnology....

Garri Zmudze, a Longevity and biotech VC, highlighted LongeVC's focus on diagnostics with portfolio companies like AOA Dx, Melio, Deep Longevity, SiPhox Health, PreComb, and Haut.AI...

LongeVC has topped up the investment in their portfolio company SiPhox Health to make at-home blood testing more accessible and user-friendly...

LongeVC has backed SiPhox Health, a portfolio company, in its latest funding round as SiPhox doubled its revenue in 2024 and advanced in product development and R&D...

LongeVC's portfolio company HautAI launched SkinGPT, an AI platform for personalized virtual skincare try-ons, using generative AI to simulate product effects and skin changes...

Unnatural Products Inc., a LongeVC portfolio company, is pioneering AI-powered macrocyclic molecule design in collaboration with Merck to enhance drug discovery for complex diseases...

LongeVC's portfolio company Melio, led by Mridu Sinha, received a $3.5M grant to develop a platform for rapid identification of bloodstream infections, starting with neonatal sepsis...

LongeVC's comparative indices for 2023 show slight improvements in net turnover, equity capital, fixed assets, balance, tangible assets, and liquidity...

LongeVC's portfolio company Longenesis has partnered with Novartis Baltics on a pilot project to transform cardiovascular disease treatment and prevention in Latvia...